Evidence map›Paper›PMID 38572492›Full record

ArticleFrontiers in neurology2024

IgLON5 autoimmunity in a patient with Creutzfeldt-Jakob disease: case report and review of literature.

Xiaofeng Li, Yimin Chen, Le Zhang, Wei Zhang, Bin Li, José Fidel Baizabal-Carvallo, Xingwang Song

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Xiaofeng LiDepartment of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yimin ChenDepartment of Neurology, Foshan Sanshui District People's Hospital, Foshan, Guangdong, China.
Le ZhangDepartment of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wei ZhangDepartment of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Bin LiDepartment of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
José Fidel Baizabal-CarvalloDepartment of Sciences and Engineering, University of Guanajuato, León, Mexico.
Xingwang SongDepartment of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Second Affiliated Hospital of Guangzhou Medical University · CNGuangzhou Medical University · CNFoshan Second People's Hospital · CNUniversidad de Guanajuato · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We present the case of a patient with clinical and imaging features of sporadic Creutzfeldt-Jakob disease (sCJD) and positive IgLON5 antibodies (Abs) in the serum and CSF. Case report: A 66-year-old Chinese man presented to the hospital with a stroke-like episode, followed by rapidly progressive cognitive decline, mutism, and parkinsonism. The MRI results showed a cortical ribboning sign in diffusion-weighted MRI, periodic triphasic waves with a slow background in EEG, and positive protein 14-3-3 in CSF. There were matching IgLON5 Abs in the serum and CSF. A literature review showed positive autoimmune encephalitis Abs or autoimmune inflammatory disease between 0.5 and 8.6% among patients with clinical suspicion of CJD, most commonly anti-voltage-gated potassium channel (VGKC) complex and anti-N-methyl-D-aspartate receptor (NMDAR) Abs; however, IgLON5 autoimmunity in CJD has been rarely reported. This is an intriguing association as both conditions have been associated with brain deposits of phosphorylated tau protein. Conclusion: IgLON5 Abs may be observed in patients with a diagnosis of CJD; it is unknown whether a synergistic effect of IgLON5 Abs with CJD exists, increasing neurodegenerative changes.

Indexed as

autoimmune encephalitisCreutzfeldt–Jakob diseaseIgLON5 antibodiesneurodegenerative diseaserapid progressive dementia

Identifiers

PMID38572492
PMCPMC10989518
OpenAlexW4392988860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.